# Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients

> **NCT02078323** · NA · COMPLETED · sponsor: **Augusta University** · enrollment: 39 (actual)

## Conditions studied

- Irritable Bowel Syndrome With Constipation (IBS-C)

## Interventions

- **DRUG:** Linaclotide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02078323
- **Lead sponsor:** Augusta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-02
- **Primary completion:** 2017-10-04
- **Final completion:** 2018-07-20
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2018-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02078323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02078323, "Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02078323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*